Myocardial Infarction Within One Year of Total Hip Arthroplasty Increases Medical Complications in a Time-Dependent

Alejandro M Holle1, Sayi P Boddu1, Jens T Verhey2

  • 1Mayo Clinic Alix School of Medicine, Scottsdale, Arizona.

PubMed

Insights

A recent myocardial infarction (MI) within six months before total hip arthroplasty (THA) significantly increases the risk of postoperative complications, including heart failure and mortality. Specific MI types and treatments further elevate these risks.

Area of Science:

  • Cardiology
  • Orthopedic Surgery
  • Health Services Research

Background:

  • Myocardial infarction (MI) is a critical comorbidity impacting surgical outcomes.
  • Understanding the perioperative risks associated with prior MI before total hip arthroplasty (THA) is essential for patient management.

Purpose of the Study:

  • To investigate the influence of the timing, type, and treatment of myocardial infarction (MI) preceding total hip arthroplasty (THA) on postoperative cardiac and general medical complications.

Main Methods:

  • A retrospective analysis of a national administrative claims database was performed.
  • Patients undergoing primary THA were identified and matched with controls.
  • MI patients were stratified by the timing of their MI before THA (0-6, 6-12, 12-18, 18-24 months).

Main Results:

  • A history of MI significantly increased the risk of postoperative MI (OR: 4.06), heart failure (OR: 1.65), and 90-day mortality (OR: 2.22).
  • The highest risk of postoperative MI was observed within 6 months of THA, especially for type 1 MI (OR: 8.07) and percutaneous coronary intervention (PCI)-treated MI (OR: 14.09).
  • ST-segment elevation myocardial infarctions (STEMIs) were associated with increased 90-day mortality (OR: 2.69), and inferior infarcts were linked to higher risks of postoperative MI and mortality.

Conclusions:

  • Myocardial infarction occurring within six months prior to THA, particularly type 1 MI, STEMI, PCI-treated MI, and inferior MI, poses the greatest risk for adverse postoperative outcomes.
  • These findings highlight the importance of considering MI timing, type, and treatment when assessing surgical risk for THA patients.
Abstract

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
17
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
52
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
35
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
169
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
28
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
32